TickerFactsScreenerDevelopers

ENDONOVO THERAPEUTICS, INC. (ENDV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: $8.5K2011: -$50.4K2012: -$284.9K2013: -$257.4K2014: -$909.3K2015: -$1.02M2016: -$2.46M2017: -$2.99M2018: -$2.88M2019: -$2.54M2020: -$741.6K2021: -$986.6K2022: -$678.8K-$678.8K
2010Operating Cash Flow (USD)2022
Fiscal YearOperating Cash FlowChange YoY
2022-$678.8K+31.2%
2021-$986.6K-33.0%
2020-$741.6K+70.8%
2019-$2.54M+11.7%
2018-$2.88M+3.7%
2017-$2.99M-21.4%
2016-$2.46M-141.6%
2015-$1.02M-12.1%
2014-$909.3K-253.2%
2013-$257.4K+9.6%
2012-$284.9K-465.8%
2011-$50.4K-692.3%
2010$8.5K—